{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:12:55Z","timestamp":1793229175858,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ZonMw-TOP","award":["91214038"],"award-info":[{"award-number":["91214038"]}]},{"name":"NWO Domain Applied and Engineering Sciences","award":["13259"],"award-info":[{"award-number":["13259"]}]},{"name":"7th Framework Programme for Research","award":["N\u00b0 PhagoSys HEALTH-F4-2008-223451"],"award-info":[{"award-number":["N\u00b0 PhagoSys HEALTH-F4-2008-223451"]}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2017\/03332-5"],"award-info":[{"award-number":["2017\/03332-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The persistent increase of multidrug-resistant (MDR)\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (\n                    <jats:italic>Mtb<\/jats:italic>\n                    ) infections negatively impacts Tuberculosis treatment outcomes. Host-directed therapies (HDT) pose an complementing strategy, particularly since\n                    <jats:italic>Mtb<\/jats:italic>\n                    is highly successful in evading host-defense by manipulating host-signaling pathways. Here, we screened a library containing autophagy-modulating compounds for their ability to inhibit intracellular\n                    <jats:italic>Mtb<\/jats:italic>\n                    -bacteria. Several active compounds were identified, including two drugs of the diphenylbutylpiperidine-class, Fluspirilene and Pimozide, commonly used as antipsychotics. Both molecules inhibited intracellular\n                    <jats:italic>Mtb<\/jats:italic>\n                    in pro- as well as anti-inflammatory primary human macrophages in a host-directed manner and synergized with conventional anti-bacterials. Importantly, these inhibitory effects extended to MDR-\n                    <jats:italic>Mtb<\/jats:italic>\n                    strains and the unrelated intracellular pathogen,\n                    <jats:italic>Salmonella enterica<\/jats:italic>\n                    serovar Typhimurium (\n                    <jats:italic>Stm<\/jats:italic>\n                    ). Mechanistically Fluspirilene and Pimozide were shown to regulate autophagy and alter the lysosomal response, partly correlating with increased bacterial localization to autophago(lyso)somes. Pimozide\u2019s and Fluspirilene\u2019s efficacy was inhibited by antioxidants, suggesting involvement of the oxidative-stress response in\n                    <jats:italic>Mtb<\/jats:italic>\n                    growth control. Furthermore, Fluspirilene and especially Pimozide counteracted\n                    <jats:italic>Mtb<\/jats:italic>\n                    -induced STAT5 phosphorylation, thereby reducing\n                    <jats:italic>Mtb<\/jats:italic>\n                    phagosome-localized CISH that promotes phagosomal acidification. In conclusion, two approved antipsychotic drugs, Pimozide and Fluspirilene, constitute highly promising and rapidly translatable candidates for HDT against\n                    <jats:italic>Mtb<\/jats:italic>\n                    and\n                    <jats:italic>Stm<\/jats:italic>\n                    and act by modulating the autophagic\/lysosomal response by multiple mechanisms.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-98980-z","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T13:14:08Z","timestamp":1633353248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections"],"prefix":"10.1038","volume":"11","author":[{"given":"M. T.","family":"Heemskerk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Korbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Esselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Carvalho","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. F.","family":"Gordijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vrieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Walburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Engele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A. W.","family":"Verreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-3403","authenticated-orcid":false,"given":"T. H. M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Haks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"issue":"9","key":"98980_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/infdis\/jiu625","volume":"211","author":"RD Turner","year":"2015","unstructured":"Turner, R. D. & Bothamley, G. H. Cough and the transmission of tuberculosis. J. Infect. Dis. 211(9), 1367\u20131372 (2015).","journal-title":"J. Infect. Dis."},{"key":"98980_CR2","first-page":"2020","volume-title":"Global Tuberculosis Report 2020","author":"WHO","year":"2020","unstructured":"WHO. Global Tuberculosis Report 2020 2020 (World Health Organization, 2020)."},{"key":"98980_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.smim.2018.07.001","volume":"39","author":"M Coppola","year":"2018","unstructured":"Coppola, M. & Ottenhoff, T. H. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination. Semin. Immunol. 39, 88\u2013101 (2018).","journal-title":"Semin. Immunol."},{"issue":"8","key":"98980_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen, P. & Doherty, T. M. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3(8), 656\u2013662 (2005).","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"98980_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nri3858","volume":"15","author":"JJ Gilchrist","year":"2015","unstructured":"Gilchrist, J. J., MacLennan, C. A. & Hill, A. V. Genetic susceptibility to invasive Salmonella disease. Nat. Rev. Immunol. 15(7), 452\u2013463 (2015).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"98980_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/650733","volume":"50","author":"SE Majowicz","year":"2010","unstructured":"Majowicz, S. E. et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 50(6), 882\u2013889 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"98980_CR7","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/nmicrobiol.2015.23","volume":"1","author":"EJ Klemm","year":"2016","unstructured":"Klemm, E. J. et al. Emergence of host-adapted Salmonella Enteritidis through rapid evolution in an immunocompromised host. Nat. Microbiol. 1, 15023 (2016).","journal-title":"Nat. Microbiol."},{"key":"98980_CR8","unstructured":"TB Alliance Pipeline. https:\/\/www.tballiance.org\/portfolio."},{"issue":"10","key":"98980_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie, F. et al. Treatment of highly drug-resistant pulmonary tuberculosis. N. Engl. J. Med. 382(10), 893\u2013902 (2020).","journal-title":"N. Engl. J. Med."},{"key":"98980_CR10","unstructured":"Alliance, T. Pretomanid and BPaL Regimen for Treatment of Highly Resistant Tuberculosis. Oral presentation at Antimicrobial Drugs Advisory Committee (2019)."},{"issue":"8","key":"98980_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221688","volume":"14","author":"Z Charyeva","year":"2019","unstructured":"Charyeva, Z. et al. What works best for ensuring treatment adherence. Lessons from a social support program for people treated for tuberculosis in Ukraine. PLoS ONE 14(8), e0221688 (2019).","journal-title":"PLoS ONE"},{"issue":"8","key":"98980_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.drudis.2017.05.005","volume":"22","author":"A Machelart","year":"2017","unstructured":"Machelart, A. et al. Host-directed therapies offer novel opportunities for the fight against tuberculosis. Drug Discov. Today 22(8), 1250\u20131257 (2017).","journal-title":"Drug Discov. Today"},{"issue":"1","key":"98980_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann, S. H. E. et al. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug. Discov. 17(1), 35\u201356 (2018).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"98980_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12951","volume":"301","author":"G Kilinc","year":"2021","unstructured":"Kilinc, G. et al. Host-directed therapy to combat mycobacterial infections*. Immunol. Rev. 301, 62\u201383 (2021).","journal-title":"Immunol. Rev."},{"issue":"10","key":"98980_CR15","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.4049\/jimmunol.0901367","volume":"183","author":"S Nair","year":"2009","unstructured":"Nair, S. et al. The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. J. Immunol. 183(10), 6269\u20136281 (2009).","journal-title":"J. Immunol."},{"issue":"1","key":"98980_CR16","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/22221751.2019.1649097","volume":"8","author":"KL Zhou","year":"2019","unstructured":"Zhou, K. L. et al. Mycobacterial mannose-capped lipoarabinomannan: A modulator bridging innate and adaptive immunity. Emerg. Microbes. Infect. 8(1), 1168\u20131177 (2019).","journal-title":"Emerg. Microbes. Infect."},{"issue":"3","key":"98980_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.amjms.2018.12.003","volume":"357","author":"C Carranza","year":"2019","unstructured":"Carranza, C. & Chavez-Galan, L. Several routes to the same destination: Inhibition of phagosome-lysosome fusion by Mycobacterium tuberculosis. Am. J. Med. Sci. 357(3), 184\u2013194 (2019).","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"98980_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/imr.12268","volume":"264","author":"Z Hmama","year":"2015","unstructured":"Hmama, Z. et al. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis. Immunol. Rev. 264(1), 220\u2013232 (2015).","journal-title":"Immunol. Rev."},{"issue":"11","key":"98980_CR19","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.3390\/ijms21113985","volume":"21","author":"A Ly","year":"2020","unstructured":"Ly, A. & Liu, J. Mycobacterial virulence factors: Surface-exposed lipids and secreted proteins. Int. J. Mol. Sci. 21(11), 3985 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"98980_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jmii.2014.11.008","volume":"49","author":"D Huang","year":"2016","unstructured":"Huang, D. & Bao, L. Mycobacterium tuberculosis EspB protein suppresses interferon-gamma-induced autophagy in murine macrophages. J. Microbiol. Immunol. Infect. 49(6), 859\u2013865 (2016).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7170","key":"98980_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature06345","volume":"450","author":"C Kuijl","year":"2007","unstructured":"Kuijl, C. et al. Intracellular bacterial growth is controlled by a kinase network around PKB\/AKT1. Nature 450(7170), 725 (2007).","journal-title":"Nature"},{"issue":"1","key":"98980_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41467-017-02777-6","volume":"9","author":"CJ Korbee","year":"2018","unstructured":"Korbee, C. J. et al. Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials. Nat. Commun. 9(1), 358 (2018).","journal-title":"Nat. Commun."},{"key":"98980_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2020.00036","volume":"11","author":"JD Moreira","year":"2020","unstructured":"Moreira, J. D. et al. Functional inhibition of host histone deacetylases (HDACs) enhances in vitro and in vivo anti-mycobacterial activity in human macrophages and in Zebrafish. Front. Immunol. 11, 36 (2020).","journal-title":"Front. Immunol."},{"issue":"4","key":"98980_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000839","volume":"6","author":"S Jayaswal","year":"2010","unstructured":"Jayaswal, S. et al. Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen. PLoS Pathog. 6(4), e1000839 (2010).","journal-title":"PLoS Pathog."},{"issue":"5","key":"98980_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2010.02.012","volume":"140","author":"D Kumar","year":"2010","unstructured":"Kumar, D. et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140(5), 731\u2013743 (2010).","journal-title":"Cell"},{"issue":"2","key":"98980_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.chom.2013.01.008","volume":"13","author":"V Sundaramurthy","year":"2013","unstructured":"Sundaramurthy, V. et al. Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe. 13(2), 129\u2013142 (2013).","journal-title":"Cell Host Microbe."},{"issue":"6","key":"98980_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.chom.2014.05.005","volume":"15","author":"M van der Vaart","year":"2014","unstructured":"van der Vaart, M. et al. The DNA damage-regulated autophagy modulator DRAM1 links mycobacterial recognition via TLR-MYD88 to autophagic defense [corrected]. Cell Host Microbe. 15(6), 753\u2013767 (2014).","journal-title":"Cell Host Microbe."},{"issue":"6","key":"98980_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","volume":"119","author":"MG Gutierrez","year":"2004","unstructured":"Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119(6), 753\u2013766 (2004).","journal-title":"Cell"},{"issue":"2","key":"98980_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2014.03.009","volume":"54","author":"LC Gomes","year":"2014","unstructured":"Gomes, L. C. & Dikic, I. Autophagy in antimicrobial immunity. Mol. Cell 54(2), 224\u2013233 (2014).","journal-title":"Mol. Cell"},{"issue":"5792","key":"98980_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1126\/science.1129577","volume":"313","author":"SB Singh","year":"2006","unstructured":"Singh, S. B. et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313(5792), 1438\u20131441 (2006).","journal-title":"Science"},{"issue":"1","key":"98980_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","volume":"161","author":"J Harris","year":"2010","unstructured":"Harris, J. & Keane, J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin. Exp. Immunol. 161(1), 1\u20139 (2010).","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"98980_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2012.06.040","volume":"150","author":"RO Watson","year":"2012","unstructured":"Watson, R. O., Manzanillo, P. S. & Cox, J. S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150(4), 803\u2013815 (2012).","journal-title":"Cell"},{"issue":"3","key":"98980_CR33","doi-asserted-by":"publisher","first-page":"1801695","DOI":"10.1183\/13993003.01695-2018","volume":"53","author":"MJ Magee","year":"2019","unstructured":"Magee, M. J. et al. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins. Eur. Respir. J. 53(3), 1801695 (2019).","journal-title":"Eur. Respir. J."},{"issue":"5","key":"98980_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3904\/kjim.2017.249","volume":"33","author":"YJ Lee","year":"2018","unstructured":"Lee, Y. J. et al. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus. Korean J. Int. Med. 33(5), 933\u2013940 (2018).","journal-title":"Korean J. Int. Med."},{"key":"98980_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fmicb.2020.00435","volume":"11","author":"N Naicker","year":"2020","unstructured":"Naicker, N., Sigal, A. & Naidoo, K. Metformin as host-directed therapy for TB treatment: Scoping review. Front. Microbiol. 11, 435 (2020).","journal-title":"Front. Microbiol."},{"key":"98980_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7617023","volume":"2018","author":"PD Guerra-De-Blas","year":"2018","unstructured":"Guerra-De-Blas, P. D. et al. Potential effect of statins on Mycobacterium tuberculosis infection. J. Immunol. Res. 2018, 1\u201314 (2018).","journal-title":"J. Immunol. Res."},{"issue":"3","key":"98980_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1570163814666170727130003","volume":"15","author":"A Shakya","year":"2018","unstructured":"Shakya, A., Bhat, H. R. & Ghosh, S. K. Update on nitazoxanide: A multifunctional chemotherapeutic agent. Curr. Drug Discov. Technol. 15(3), 201\u2013213 (2018).","journal-title":"Curr. Drug Discov. Technol."},{"issue":"5","key":"98980_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.chom.2011.09.010","volume":"10","author":"RJ Napier","year":"2011","unstructured":"Napier, R. J. et al. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe. 10(5), 475\u2013485 (2011).","journal-title":"Cell Host Microbe."},{"issue":"8","key":"98980_CR39","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.4049\/jimmunol.1201538","volume":"189","author":"H Bruns","year":"2012","unstructured":"Bruns, H. et al. Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages. J. Immunol. 189(8), 4069\u20134078 (2012).","journal-title":"J. Immunol."},{"issue":"3","key":"98980_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004770","volume":"11","author":"RJ Napier","year":"2015","unstructured":"Napier, R. J. et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog. 11(3), e1004770 (2015).","journal-title":"PLoS Pathog."},{"issue":"16","key":"98980_CR41","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1073\/pnas.80.16.5122","volume":"80","author":"RJ Gould","year":"1983","unstructured":"Gould, R. J. et al. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. U. S. A. 80(16), 5122\u20135125 (1983).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"98980_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1189\/jlb.0105015","volume":"79","author":"FA Verreck","year":"2006","unstructured":"Verreck, F. A. et al. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukoc. Biol. 79(2), 285\u2013293 (2006).","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"98980_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180922","volume":"12","author":"KR Gillinder","year":"2017","unstructured":"Gillinder, K. R. et al. Direct targets of pSTAT5 signalling in erythropoiesis. PLoS ONE 12(7), e0180922 (2017).","journal-title":"PLoS ONE"},{"issue":"7","key":"98980_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9(7), 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"issue":"7","key":"98980_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin, C. et al. Cell profiler 3.0: Next-generation image processing for biology. PLoS Biol. 16(7), e2005970 (2018).","journal-title":"PLoS Biol."},{"issue":"4","key":"98980_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25(4), 402\u2013408 (2001).","journal-title":"Methods"},{"issue":"518","key":"98980_CR47","doi-asserted-by":"publisher","first-page":"eaaw6635","DOI":"10.1126\/scitranslmed.aaw6635","volume":"11","author":"R Mishra","year":"2019","unstructured":"Mishra, R. et al. Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis. Sci. Transl. Med. 11(518), eaaw6635 (2019).","journal-title":"Sci. Transl. Med."},{"issue":"13","key":"98980_CR48","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1073\/pnas.0400983101","volume":"101","author":"FA Verreck","year":"2004","unstructured":"Verreck, F. A. et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U. S. A. 101(13), 4560\u20134565 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"98980_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chom.2012.03.008","volume":"11","author":"JJ Kim","year":"2012","unstructured":"Kim, J. J. et al. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe. 11(5), 457\u2013468 (2012).","journal-title":"Cell Host Microbe."},{"issue":"48","key":"98980_CR50","doi-asserted-by":"publisher","first-page":"19023","DOI":"10.1073\/pnas.0709695104","volume":"104","author":"L Zhang","year":"2007","unstructured":"Zhang, L. et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl. Acad. Sci. U. S. A. 104(48), 19023\u201319028 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"98980_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb2718","volume":"15","author":"C Settembre","year":"2013","unstructured":"Settembre, C. et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 15(6), 647\u2013658 (2013).","journal-title":"Nat. Cell Biol."},{"key":"98980_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcell.2019.00114","volume":"7","author":"C Di Malta","year":"2019","unstructured":"Di Malta, C., Cinque, L. & Settembre, C. Transcriptional regulation of autophagy: Mechanisms and diseases. Front. Cell Dev. Biol. 7, 114 (2019).","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"98980_CR53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41419-018-1227-0","volume":"9","author":"B Zhitomirsky","year":"2018","unstructured":"Zhitomirsky, B. et al. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death Dis. 9(12), 1191 (2018).","journal-title":"Cell Death Dis."},{"issue":"12","key":"98980_CR54","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","volume":"117","author":"EA Nelson","year":"2011","unstructured":"Nelson, E. A. et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 117(12), 3421\u20133429 (2011).","journal-title":"Blood"},{"issue":"13","key":"98980_CR55","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1016\/j.celrep.2017.08.101","volume":"20","author":"CJ Queval","year":"2017","unstructured":"Queval, C. J. et al. Mycobacterium tuberculosis controls phagosomal acidification by targeting CISH-mediated signaling. Cell Rep. 20(13), 3188\u20133198 (2017).","journal-title":"Cell Rep."},{"issue":"3","key":"98980_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1189\/jlb.71.3.511","volume":"71","author":"A Lehtonen","year":"2002","unstructured":"Lehtonen, A. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte\/macrophage differentiation. J. Leukoc. Biol. 71(3), 511\u2013519 (2002).","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"98980_CR57","first-page":"3853","volume":"9","author":"N Cai","year":"2017","unstructured":"Cai, N. et al. The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. Am. J. Transl. Res. 9(8), 3853\u20133866 (2017).","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"98980_CR58","first-page":"1101","volume":"42","author":"JJ Chen","year":"2019","unstructured":"Chen, J. J. et al. Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer. Oncol. Rep. 42(3), 1101\u20131109 (2019).","journal-title":"Oncol. Rep."},{"issue":"10","key":"98980_CR59","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41419-018-1003-1","volume":"9","author":"S Zielke","year":"2018","unstructured":"Zielke, S. et al. Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells. Cell Death Dis. 9(10), 994 (2018).","journal-title":"Cell Death Dis."},{"issue":"8","key":"98980_CR60","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","volume":"41","author":"GK Azad","year":"2014","unstructured":"Azad, G. K. & Tomar, R. S. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways. Mol. Biol. Rep. 41(8), 4865\u20134879 (2014).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"98980_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","volume":"107","author":"AE Dikalova","year":"2010","unstructured":"Dikalova, A. E. et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107(1), 106\u2013116 (2010).","journal-title":"Circ. Res."},{"issue":"4787","key":"98980_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.2432665","volume":"235","author":"JB Hibbs Jr","year":"1987","unstructured":"Hibbs, J. B. Jr., Taintor, R. R. & Vavrin, Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235(4787), 473\u2013476 (1987).","journal-title":"Science"},{"issue":"4","key":"98980_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01534-14","volume":"5","author":"DM Czyz","year":"2014","unstructured":"Czyz, D. M. et al. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens. MBio 5(4), e015344-14 (2014).","journal-title":"MBio"},{"issue":"8","key":"98980_CR64","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3390\/ijms21082855","volume":"21","author":"Q Shi","year":"2020","unstructured":"Shi, Q. et al. Mechanisms of action of autophagy modulators dissected by quantitative systems pharmacology analysis. Int. J. Mol. Sci. 21(8), 2855 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"98980_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01943-17","volume":"62","author":"JA Andersson","year":"2018","unstructured":"Andersson, J. A. et al. Combating multidrug-resistant pathogens with host-directed nonantibiotic therapeutics. Antimicrob. Agents Chemother. 62(1), e01943-17 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"98980_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189950","volume":"13","author":"H Nehme","year":"2018","unstructured":"Nehme, H. et al. Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. PLoS ONE 13(1), e0189950 (2018).","journal-title":"PLoS ONE"},{"issue":"2","key":"98980_CR67","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1128\/AAC.00607-08","volume":"53","author":"LA Lieberman","year":"2009","unstructured":"Lieberman, L. A. & Higgins, D. E. A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection. Antimicrob. Agents Chemother. 53(2), 756\u2013764 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"98980_CR68","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00042-15","volume":"1","author":"AJ Dittmar","year":"2016","unstructured":"Dittmar, A. J., Drozda, A. A. & Blader, I. J. Drug repurposing screening identifies novel compounds that effectively inhibit Toxoplasma gondii growth. Msphere 1(2), e00042-15 (2016).","journal-title":"Msphere"},{"issue":"8","key":"98980_CR69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00769-19","volume":"63","author":"CK Hind","year":"2019","unstructured":"Hind, C. K. et al. Evaluation of a library of FDA-approved drugs for their ability to potentiate antibiotics against multidrug-resistant gram-negative pathogens. Antimicrob. Agents Chemother. 63(8), e00769-19 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"98980_CR70","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fcimb.2018.00438","volume":"8","author":"YS Cheng","year":"2019","unstructured":"Cheng, Y. S. et al. Repurposing screen identifies unconventional drugs with activity against multidrug resistant Acinetobacter baumannii. Front. Cell. Infect. Microb. 8, 438 (2019).","journal-title":"Front. Cell. Infect. Microb."},{"issue":"1","key":"98980_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4161\/auto.6.1.10326","volume":"6","author":"HG Xia","year":"2010","unstructured":"Xia, H. G. et al. Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy 6(1), 61\u201366 (2010).","journal-title":"Autophagy"},{"issue":"11","key":"98980_CR72","doi-asserted-by":"publisher","first-page":"282","DOI":"10.15698\/cst2018.11.161","volume":"2","author":"L Vucicevic","year":"2018","unstructured":"Vucicevic, L. et al. Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs. Cell Stress 2(11), 282\u2013291 (2018).","journal-title":"Cell Stress"},{"key":"98980_CR73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fcimb.2020.00461","volume":"10","author":"R Garg","year":"2020","unstructured":"Garg, R. et al. Mycobacterium tuberculosis calcium pump CtpF modulates the autophagosome in an mTOR-dependent manner. Front. Cell. Infect. Microbiol. 10, 461 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"98980_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bmcl.2010.11.029","volume":"21","author":"G Chen","year":"2011","unstructured":"Chen, G. et al. Synthesis and SAR study of diphenylbutylpiperidines as cell autophagy inducers. Bioorg. Med. Chem. Lett. 21(1), 234\u2013239 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5939","key":"98980_CR75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325(5939), 473\u2013477 (2009).","journal-title":"Science"},{"issue":"6","key":"98980_CR76","first-page":"972","volume":"14","author":"N Singh","year":"2018","unstructured":"Singh, N. et al. Antimycobacterial effect of IFNG (interferon gamma)-induced autophagy depends on HMOX1 (heme oxygenase 1)-mediated increase in intracellular calcium levels and modulation of PPP3\/calcineurin-TFEB (transcription factor EB) axis. Autophagy 14(6), 972\u2013991 (2018).","journal-title":"Autophagy"},{"issue":"4","key":"98980_CR77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chembiol.2017.03.005","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Rescue of pink1 deficiency by stress-dependent activation of autophagy. Cell Chem. Biol. 24(4), 471\u2013480 (2017).","journal-title":"Cell Chem. Biol."},{"key":"98980_CR78","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fphar.2019.01517","volume":"10","author":"U Kim","year":"2020","unstructured":"Kim, U. et al. Pimozide inhibits the human prostate cancer cells through the generation of reactive oxygen species. Front. Pharmacol. 10, 1517 (2020).","journal-title":"Front. Pharmacol."},{"issue":"6","key":"98980_CR79","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.chembiol.2012.04.015","volume":"19","author":"SM Smith","year":"2012","unstructured":"Smith, S. M. et al. Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. Chem. Biol. 19(6), 752\u2013763 (2012).","journal-title":"Chem. Biol."},{"key":"98980_CR80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fmed.2017.00252","volume":"4","author":"A Mullebner","year":"2018","unstructured":"Mullebner, A. et al. Interaction between mitochondrial reactive oxygen species, heme oxygenase, and nitric oxide synthase stimulates phagocytosis in macrophages. Front. Med. 4, 452 (2018).","journal-title":"Front. Med."},{"issue":"7344","key":"98980_CR81","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature09973","volume":"472","author":"AP West","year":"2011","unstructured":"West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472(7344), 476-U543 (2011).","journal-title":"Nature"},{"issue":"2","key":"98980_CR82","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","volume":"13","author":"C Young","year":"2020","unstructured":"Young, C., Walzl, G. & Du Plessis, N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal. Immunol. 13(2), 190\u2013204 (2020).","journal-title":"Mucosal. Immunol."},{"key":"98980_CR83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.micro.61.111606.122346","volume":"61","author":"C Vilcheze","year":"2007","unstructured":"Vilcheze, C. & Jacobs, W. R. The mechanism of isoniazid killing: Clarity through the scope of genetics. Annu. Rev. Microbiol. 61, 35\u201350 (2007).","journal-title":"Annu. Rev. Microbiol."},{"key":"98980_CR84","unstructured":"(FDA), F.a.D.A. ORAP (Pimozide) (2011)."},{"issue":"3","key":"98980_CR85","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/JCP.0000000000000319","volume":"35","author":"K van der Weide","year":"2015","unstructured":"van der Weide, K. & van der Weide, J. The influence of the CYP3A4*22 polymorphism and CYP2D6 polymorphisms on serum concentrations of aripiprazole, haloperidol, pimozide, and risperidone in psychiatric patients. J. Clin. Psychopharmacol. 35(3), 228\u2013236 (2015).","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"98980_CR86","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/17425247.2021.1886074","volume":"18","author":"AD Brunaugh","year":"2021","unstructured":"Brunaugh, A. D., Sharma, S. & Smyth, H. Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opin. Drug Deliv. 18(8), 1101\u20131115 (2021).","journal-title":"Expert Opin. Drug Deliv."},{"issue":"8","key":"98980_CR87","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s11095-016-1926-0","volume":"33","author":"A Gupta","year":"2016","unstructured":"Gupta, A. et al. Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy. Pharm. Res. 33(8), 1899\u20131912 (2016).","journal-title":"Pharm. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98980-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T07:39:54Z","timestamp":1706168394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98980-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98980"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98980-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.05.447191","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19634"}}